| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3115065
Max Phase: Preclinical
Molecular Formula: C17H18ClN3O4
Molecular Weight: 363.80
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C1N[C@@H](C(=O)O)Cc2cn(cn2)CCCCOc2ccc(Cl)c1c2
Standard InChI: InChI=1S/C17H18ClN3O4/c18-14-4-3-12-8-13(14)16(22)20-15(17(23)24)7-11-9-21(10-19-11)5-1-2-6-25-12/h3-4,8-10,15H,1-2,5-7H2,(H,20,22)(H,23,24)/t15-/m1/s1
Standard InChI Key: CNVZYIOAIFJZCD-OAHLLOKOSA-N
Associated Targets(Human)
Integrin alpha2/beta1 69 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 363.80 | Molecular Weight (Monoisotopic): 363.0986 | AlogP: 2.13 | #Rotatable Bonds: 1 |
| Polar Surface Area: 93.45 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.36 | CX Basic pKa: 6.12 | CX LogP: 0.44 | CX LogD: -0.79 |
| Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.81 | Np Likeness Score: 0.28 |
References
| 1. Halland N, Blum H, Buning C, Kohlmann M, Lindenschmidt A.. (2014) Small Macrocycles As Highly Active Integrin α2β1 Antagonists., 5 (2): [PMID:24900800] [10.1021/ml4004556] |
Source
Source(1):